Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001062993-25-002744
Filing Date
2025-02-18
Accepted
2025-02-18 20:21:32
Documents
1
Period of Report
2025-02-13

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.xml 4 18294
  Complete submission text file 0001062993-25-002744.txt   19894
Mailing Address 1165 EASTLAKE AVE E SEATTLE WA 98109
Business Address 1165 EASTLAKE AVE E SEATTLE WA 98109 206-659-0067
Adaptive Biotechnologies Corp (Issuer) CIK: 0001478320 (see all company filings)

EIN.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION 1551 EASTLAKE AVE E STE 200 SEATTLE WA 98102
Business Address
ROBINS CHAD M (Reporting) CIK: 0001780649 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38957 | Film No.: 25636895